Weller M - Search Results

1

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ. Wen PY, et al. Among authors: weller m. Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106. Neuro Oncol. 2020. PMID: 32328653 Free PMC article. Review.

2

New aspects of immunotherapy of leptomeningeal metastasis.

Herrlinger U, Weller M, Schabet M. Herrlinger U, et al. Among authors: weller m. J Neurooncol. 1998 Jun-Jul;38(2-3):233-9. doi: 10.1023/a:1005948722912. J Neurooncol. 1998. PMID: 9696377 Review.

3

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

4

Soluble CD95 (Fas/APO-1) in malignant glioma: (no) implications for CD95-based immunotherapy?

Streffer JR, Schuster M, Zipp F, Weller M. Streffer JR, et al. Among authors: weller m. J Neurooncol. 1998 Dec;40(3):233-5. doi: 10.1023/a:1006173019048. J Neurooncol. 1998. PMID: 10066095

5

Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.

Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M. Wick W, et al. Among authors: weller m. J Pharmacol Exp Ther. 1999 Jun;289(3):1306-12. J Pharmacol Exp Ther. 1999. PMID: 10336521

6

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.

Ständer M, Naumann U, Wick W, Weller M. Ständer M, et al. Among authors: weller m. Cell Tissue Res. 1999 May;296(2):221-7. doi: 10.1007/s004410051283. Cell Tissue Res. 1999. PMID: 10382266 Review.

7

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M. Wick W, et al. Among authors: weller m. Oncogene. 1999 Jul 8;18(27):3936-43. doi: 10.1038/sj.onc.1202774. Oncogene. 1999. PMID: 10435616

8

Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.

Pohl U, Wick W, Weissenberger J, Steinbach JP, Dichgans J, Aguzzi A, Weller M. Pohl U, et al. Among authors: weller m. Int J Oncol. 1999 Oct;15(4):829-34. doi: 10.3892/ijo.15.4.829. Int J Oncol. 1999. PMID: 10493969

9

Role of TGF-beta in oncogenesis.

Weller M, Wick W, Platten M. Weller M, et al. Microsc Res Tech. 2001 Feb 15;52(4):353. doi: 10.1002/1097-0029(20010215)52:4<353::AID-JEMT1019>3.0.CO;2-U. Microsc Res Tech. 2001. PMID: 11170293 No abstract available.

10

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Among authors: weller m. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,711 results

Search Page

Filters